secwatch.observer — SEC 8-K summary
======================================

Issuer:     BeOne Medicines Ltd. (ONC)
CIK:        0001651308
Form:       8-K
Filed at:   2021-07-01T23:59:59+00:00
Accession:  0001651308-21-000145
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

BeiGene appoints Julia Wang as CFO; Howard Liang retires effective June 30, 2021
--------------------------------------------------------------------------------

- Julia Wang named CFO, principal financial and accounting officer, effective June 30, 2021.
- Annual base salary $445,000; bonus target 50% of base; equity grants vesting over four years.
- Prior CFO Howard Liang retired; no disagreement regarding financial reporting or accounting.
- Liang entered 4-month consulting agreement; unvested options continue to vest during term.
- Wang previously SVP Enterprise Optimization & Deputy CFO; prior roles at Alexion, Quest, J&J.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/0001651308-21-000145-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1651308/000165130821000145/bgne-20210630.htm
  HTML page:      https://secwatch.observer/filing/0001651308-21-000145

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer